Inflammatix

Industry · 6 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections Sepsis, Infections, Tachycardia	N/A	2024-11-08
Withdrawn	Sepsis Prognosis and Diagnosis in the Emergency Department (SPEED) Respiratory Tract Infections, Urinary Tract Infections, Intra-Abdominal Infections	—	2022-12-01
Completed	Clinical Validation of HostDx Sepsis™ on NanoString; a Prospective Observational Validation Trial Sepsis	—	2020-06-07
Completed	TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspec Respiratory Tract Infections, Urinary Tract Infections, Intra-Abdominal Infections	—	2020-02-28
Completed	HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Mul Respiratory Tract Infections, Urinary Tract Infections, Skin and Soft Tissue Infections	—	2018-07-23
Completed	Collection of Clinical Specimens From Volunteers for Assay Development Acute Respiratory Infection	—	2018-04-01